We confirmed that FOXO6, but not FOXO1, 3 or 4, was frequently overexpressed in breast cell lines (25%) and in breast tumours (26.9%) (Table 1 and Supplementary Table 2). This evidence concerns the gene FOXO6 and breast neoplasm.